A. muciniphila administration improved insulin sensitivity, reduced plasma cholesterol levels, slightly decreased body weight, fat mass and hip circumference and reduced blood markers of liver dysfunction and inflammation.9‐11 Overall gut microbiota composition was not affected and the extent to which these effects were driven by mucus modulation is unknown. Here, INS is linked to Decreased liver function.